AnergiX.MG

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAnergiX.MG
Drug Alias Nameantigen specific therapy (Corixa/Ipsen)AG2/102
ClassificationBiologics > AntigenBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCorixa Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A